Ailux Appoints Maria Belvisi as Chief Scientific Officer
Ailux has named Maria Belvisi, Ph.D., as its new Chief Scientific Officer. Belvisi joins the company following her tenure as Senior Vice President of Research and Development at AstraZeneca.
A
ailux
via Berkshireeagle.com - Corroborated by 1 others
Updated 4h ago
Why It Matters
The appointment brings significant pharmaceutical R&D leadership experience to Ailux as it continues its scientific development.
Key Points
- Maria Belvisi joins Ailux as Chief Scientific Officer.
- She previously served as Senior Vice President of R&D for Respiratory and Immunology at AstraZeneca.
- Belvisi led the development of tozorakimab from preclinical research through Phase 3 trials.
Source Verification
Corroboration Score: 2This story was independently reported by 2 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
